Physician profile
Christopher P Caputo
NPI 1063467009
$66,671.08
in general payments reported to CMS, 2019-2025
41 companies · $4,510 in 2025
The $4,510 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,784 · 2020: $3,311 · 2021: $1,933 · 2022: $4,299 · 2023: $19K · 2024: $29K · 2025: $4,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $41K · Food and Beverage: $7,478 · Travel and Lodging: $3,309 · Gift: $54.81 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $41,485.00 |
| Food and Beverage | $7,478.24 |
| Travel and Lodging | $3,308.51 |
| Gift | $54.81 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $42,076.26 | 2022-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $7,155.93 | 2021-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Abbott Laboratories | $3,150.79 | 2019-2021 | |
| Penumbra, INC. | $3,102.61 | 2019-2024 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $1,768.67 | 2019-2020 | |
| Boston Scientific Corporation | $1,664.50 | 2019-2025 | Avvigo Guidance System, Ffr Link, General - Vascular Intervention |
| Cook Medical LLC | $1,513.76 | 2019-2025 | Advance, Zilver Ptx, Torcon Nb |
| Amgen INC. | $1,213.07 | 2019-2025 | Repatha, Repatha |
| Abiomed | $1,196.35 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $517.21 | 2021-2025 | Rotarexs 6 F X 135 Cm, Venovo |
| Microvention, INC. | $400.00 | 2020 | |
| Recor Medical INC | $313.90 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $302.86 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.35 | 2020-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $216.72 | 2019-2025 | Camzyos, Eliquis |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Caputo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.